Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Rectal Neoplasms × Mastectomy, Segmental × Clear all

Phase

Phase NA 3 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 19 Triple Negative Breast Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Rectal Neoplasms 1 Neoplasm Micrometastasis 1 Lymphedema 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Oxaliplatin 129 Fluorouracil 119 Capecitabine 102 Leucovorin 94 Irinotecan 74 Radiotherapy 60 Bevacizumab 56 Cetuximab 39 Folfox protocol 25 Surgical Procedures, Operative 22 Drug Therapy 20 Radiation 18 Panitumumab 17 XELOX 16 Chemotherapy, Adjuvant 15 Neoadjuvant Therapy 14 Chemoradiotherapy 12 Radiotherapy, Intensity-Modulated 11 Floxuridine 9 regorafenib 8 Nivolumab 8 raltitrexed 7 IFL protocol 7 Celecoxib 7 trifluridine tipiracil drug combination 6 aflibercept 6 Trastuzumab 6 Melphalan 6 Immunohistochemistry 6 tislelizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05969847 2023-08-01

TRACE-LE

Fujian Medical University Union Hospital

Phase 2 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡